H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one powerflow port body and an iv adaptor were returned for evaluation.Functional, gross visual and microscopic visual evaluations were performed.The investigation is confirmed for an occlusion in the port body, as the sample was occluded before and after decontamination but with increased hydraulic effort some residue was ejected through/from the valve.The port was patent to infusion and aspiration and no leaks were observed after the residue had been ejected.Upon visual inspection, the ejected residue appeared to be dried blood which crumbled under slight pressure.The returned sample had blood and fluid residue throughout the device.The definitive root cause could not be determined based upon available information.It is unknown if procedural and/or manufacturing issues contributed to the reported event.Labeling review: the cause of the event in question is unknown, and so the applicability of any particular portion of the instructions for use (ifu) or other labeling is unknown.However, a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) showed that the ifu instructs on port placement and on accessing the port, and therefore the product labeling will be considered adequate.H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|